Clinical trial
rhTSH-Thyroid Ablation With 1850 MBq of 131I
NCT00454077 · University of Siena, Other · Completed
Key facts
| NCT number | NCT00454077 |
|---|---|
| Title | rhTSH-Thyroid Ablation With 1850 MBq of 131I |
| Official title | Recombinant Human TSH (rhTSH)-Aided Radioiodine (131) Therapy for Thyroid Remnant Ablation in Differentiated Thyroid Cancer Patients: a Comparison Between 1850 MBq and 3700 MBq Activities |
| Lead sponsor | University of Siena, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Thyroid Cancer |
| Intervention type | Procedure |
| Interventions | radioiodine therapy after rhTSH |
| Enrollment | 72 |
| Start date | Dec 1, 2004 |
| Completion | Sep 1, 2006 |
| First posted | Mar 29, 2007 |
| Last update posted | Mar 29, 2007 |
| Countries | Italy |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: